Biotechnology GBT Initiates Phase 2/3 Clinical Trial of GBT601 in Patients with Sickle Cell Disease June 29, 2022
Biotechnology SHAREHOLDER ALERT: FHS OSCR AXSM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines June 28, 2022
Biotechnology CLASS ACTION UPDATE for AXSM, TDOC and UL: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders June 28, 2022
Biotechnology Axsome Therapeutics Hosts Sunosi® Investor Update Virtual Event Today with Key Opinion Leaders June 28, 2022
Biotechnology Fate Therapeutics Announces Expansion of Solid Tumor Collaboration with ONO Pharmaceutical for Off-the-Shelf, iPSC-derived CAR NK and CAR T-Cell Cancer Immunotherapies June 28, 2022
Search
Biotechnology
